[Corrigendum] Azurocidin 1 inhibits the aberrant proliferation of triple‑negative breast cancer through the regulation of pyroptosis

Lei,Shanshan; Li,Shutong; Xiao,Weiwei; Jiang,Qiuping; Yan,Shifan; Xiao,Wen; Cai,Jiaodi; Wang,Jingjing; Zou,Lianhong; Chen,Fang; Liu,Yanjuan; Jiang,Yu

doi:10.3892/or.2024.8708

March-2024 Volume 51 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2024 Volume 51 Issue 3

Full Size Image

Correction Open Access

[Corrigendum] Azurocidin 1 inhibits the aberrant proliferation of triple‑negative breast cancer through the regulation of pyroptosis

Authors:
- Shanshan Lei
- Shutong Li
- Weiwei Xiao
- Qiuping Jiang
- Shifan Yan
- Wen Xiao
- Jiaodi Cai
- Jingjing Wang
- Lianhong Zou
- Fang Chen
- Yanjuan Liu
- Yu Jiang
View Affiliations / Copyright

Affiliations: Department of Emergency, Institute of Emergency Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410000, P.R. China, 2Department of Breast and Thyroid Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410000, P.R. China, Department of Pathology, The Fourth Hospital of Changsha, The Affiliated Changsha Hospital of Hunan Normal University, Changsha, Hunan 410000, P.R. China

Copyright: © Lei et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 49
|
Published online on: January 24, 2024

https://doi.org/10.3892/or.2024.8708
Expand metrics +

Article

Oncol Rep 50: [Related article:] 188, 2023; DOI: 10.3892/or.2023.8625

Following the publication of the above article, the authors drew to our attention that they had made a couple of inadvertent errors in assembling Figs. 4 and 5; first, for the BT-549 cell line, the data shown for the Pro-caspase-1/Cleaved caspase-1 in Fig. 5 and the GSDMD-F/GSDMD-N data in Fig. 4B were identical, and had been derived from the same original source; secondly, in Fig. 4A, the data shown correctly for the GSDMD BT-549 cell line had also inadvertently been included in this figure to represent the MDA-MB-231 cell line.

Figure 4.

GSDMD protein level is detected in TNBC cell lines with exogenous AZU1 stimuli using western blot analysis. (A) GSDMD protein level in TNBC cell lines treated with 500 ng/ml AZU1 at different time points. **P<0.01 and ***P<0.001; (n=3). (B) GSDMD protein level in TNBC cell lines treated with different concentrations of AZU1. *P<0.05, **P<0.01 and ***P<0.001; (n=3). GSDMD, gasdermin D; TNBC, triple-negative breast cancer; AZU1, azurocidin 1.

Figure 5.

Western blot analysis is conducted to investigate the protein expression levels of p-p65, p65, NLRP3, pro-caspase-1, cleaved caspase-1 and ASC in TNBC cell lines with exogenous AZU1 stimuli. *P<0.05, **P<0.01 and ***P<0.001; (n=3). NLRP3, NLR family pyrin domain containing 3; ASC, apoptosis-associated speck-like protein containing a CARD; TNBC, triple-negative breast cancer; AZU1, azurocidin 1.

The revised and corrected versions of Figs. 4 and 5, showing the correct western blotting data for the GSDMD experiment in Fig. 4A and the Pro-caspase-1/Cleaved caspase-1 data for the BT-549 cell line in Fig. 5, are shown in the next two pages. The authors regret that these errors in the assembly of Figs. 4 and 5 went unnoticed before the article was published, and thank the Editor of Oncology Reports for granting them the opportunity to publish this corrigendum. All the authors agree with the publication of this corrigendum; furthermore, they apologize to the readership of the journal for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Azurocidin 1 inhibits the aberrant proliferation of triple‑negative breast cancer through the regulation of pyroptosis

This article is mentioned in:

Article

Figure 4.

Figure 5.

Related Articles